Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Post by oiljack14on Sep 02, 2020 8:31am
210 Views
Post# 31492761

Canadian drug market study

Canadian drug market study
Most important thing you can read and understand about VPH.  Their market is Canada .  They are a specialty drug supplier to the Canadian medical market.  New study and lead study in Canada this morning states why they are so needed and valuable.  In the news story’s own words. 
 
A new study has found that of the over 9,000 different drugs marketed in Canada between 2017 and 2018, nearly 25 per cent were reported in shortage -- including EpiPens and treatments for Parkinson’s disease, epilepsy and depression.
 
 
In an unusual trend, it was more likely for a drug to be in shortage if it was produced by a generic company and there was no other competition.
 
https://www.ctvnews.ca/mobile/health/nearly-a-quarter-of-drugs-marketed-in-canada-reported-shortages-study-1.5088570
<< Previous
Bullboard Posts
Next >>